mercaptoacetyltriglycine

mercaptoacetyltriglycine

An imaging agent (99mTc-mercaptoacetyltriglycine) which has been used in preoperative renal scintigraphy to predict post-nephrectomy chronic renal insufficiency. The technique was reported to be inferior to preoperative estimated glomerular filtration rate (eGFR) in predicting the development of advanced-stage chronic kidney disease after unilateral nephrectomy.
Mentioned in ?
References in periodicals archive ?
For assessment purposes, ultrasonography (US) was taken at month 1-3 postoperatively and mercaptoacetyltriglycine (MAG-3) scintigraphy at month 6 postoperatively and, the follow-up intervals were planned accordingly.
If the MCUG shows no reflux, a mercaptoacetyltriglycine (MAG3) scan is ordered depending on the severity of the case according to our institution protocol [Figure 1].
A DMSA (dimercaptosuccinic acid) scan showed 36% function of the right kidney and a MAG-3 (mercaptoacetyltriglycine) renogram suggested moderate to severe right pelviureteric junction (PUJ) obstruction but with preserved renal function.
The visualization quality (even with a weak kidney function) of [sup.99m] Tc-technephore is comparable to that of tubulotropic [sup.99m]Tc-MAG3 (mercaptoacetyltriglycine) and 123I-hippuran, significantly outperforming conventional glomerulotropic [sup.99m]Tc-DTPA (diethylenetriaminepentaacetic acid) [21].
The ectopic left kidney had a relative function of 40% in conventional technetium-99m (Tc-99m) mercaptoacetyltriglycine (MAG3) scan.
Only 2(7%) patients in group 1 and 2(4.5%) in group 2 had poor response on mercaptoacetyltriglycine scan.
Comparison of differential renal function using technetium-99m mercaptoacetyltriglycine (MAG3) and technetium-99m dimercaptosuccinic acid (DMSA) renography in a paediatric population.
Tc-99m mercaptoacetyltriglycine (MAG3) is the most popular radiotracer used for this purpose.
Mercaptoacetyltriglycine - MAG3 Uses diuretic to evaluate suspected urinary tract obstruction.
The first diuretic renography (DR), using mercaptoacetyltriglycine (MAG-3) was performed to all patients 8-12 weeks after birth.
The mercaptoacetyltriglycine (MAG-III) renal scan showed right-side obstruction with a split function of 41.1% on the right kidney.